- PROFESSOR Genetics and Genomic Sciences
- PROFESSOR Pediatrics
- Birth Defects
- Breast Cancer
- Colorectal Cancer
- Craniofacial Anomalies
- Delayed Sexual Development
- DiGeorge Syndrome
- Ehlers-Danlos Syndrome (EDS)
- Fragile X Syndrome
- Gaucher Disease
- Genetic Counseling
- Huntington's Disease
- Intellectual Disability
- Klinefelter Syndrome
- Limb Anomalies
- Marfan Syndrome
- Multiple Congenital Anomalies
- Noonan Syndrome
- Ovarian Cancer
- Prader-Willi Syndrome
- Prenatal Diagnosis
- Rett Syndrome
- Short Stature
- Turner Syndrome
MBBS, Christian Medical College
MD, Postgraduate Inst. of Med Ed & Research
Brown Memorial Hospital
Fellowship, Hem-Clin Pathology
University College Hospital
Fellowship, Clinical Genetics
St. George's Hospital - London, UK
Fellowship, Pediatrics/Med Gen
Mount Sinai School of Medicine
Co-Director, Cardiovascular Genetics
Medical Director, MS in Genetic Counseling
Dysmorphology, Syndrome diagnosis
Prenatal Genetic Counseling and Testing
Movement Disorders; Huntington disease testing and counseling
Thomas AC, Kelsell DP, Norgett EE, Hill T, Barton S, Dale BA, Sprecher E, Sheridan E, Taylor AE, Wilroy RS, Delozier C, Burrows N, Goodyear H, Fleckman P, Stephens KG, Mehta L, Watson RM, Graham R, Wolf R, Slavotinek A, Martin M, Bourn D, Mein CA, O'Toole EA, Cullup T. ABCA12 is the major harlequin ichthyosis gene. J Invest Dermatol 2006; 126(11): 2408-2413.
Kamnasaran D, Chen CP, Cox DW, Mehta L, Devriendt K. Defining a holoprosencephaly locus on human chromosome 14q13 and characterization of potential candidate genes. Genomics 2005; 85: 608-621.
Johnston J, Olivos-Glander I, Turner J, Aleck K, Bird LM, Biesecker LG, Schimke RN, Heilstedt H, Spence JE, Blancato J, Mehta L. Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome. Am J Med Genet 2003; 123A: 236-242.
King MC, New York Breast Cancer Study Group , Mandell JB, Marks JH. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643-646.
Young ID, Mehta L, Cook JP. Changing demography of trisomy 18. Arch Dis Child 1986; 61: 1035-1036.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Mehta did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
Atran Berg Laboratory Building Floor 1 Room AB1-46
1428 Madison Avenue
New York, NY 10029
1428 Madison Avenue
New York, NY 10029
- Accept All Insurances